Tuesday, October 20, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $342.94 -0.15%
MSFT $533.52 +0.84%
GOOGL $344.18 +1.05%
AMZN $262.45 +4.98%
TSLA $368.06 +3.76%
META $705.44 -0.55%
NVDA $217.09 +1.38%
JPM $333.53 -1.82%
BTC $36.14 +0.31%
ETH $22.81 -0.74%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$342.94
▼ 0.15%
MSFT
$533.52
▲ 0.84%
GOOGL
$344.18
▲ 1.05%
AMZN
$262.45
▲ 4.98%
TSLA
$368.06
▲ 3.76%
META
$705.44
▼ 0.55%
NVDA
$217.09
▲ 1.38%
JPM
$333.53
▼ 1.82%

Top Stories

Markets →
The Guardian
Judge decides Timothy Hudson should face trial as an adult, though he will be held in an approved juvenile facilityA teenager charged with sexually assaulting and killing his 18-year-old stepsister on a Carnival Cruise ship turned himself over to the custody of federal authorities on Monday after a judge reversed his decision on pretrial release now that the teen is charged as an adult.The US attorney’s office in Miami confirmed that Timothy Hudson is in custody. US magistrate Judge Edwin Torres
general  Jun 16, 2026
Science Daily
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that people taking semaglutide experienced about 15% fewer fractures than those using other common weight-loss medications, despite losing more weight.
science  Jun 16, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free